0001209191-20-048651.txt : 20200828
0001209191-20-048651.hdr.sgml : 20200828
20200828170001
ACCESSION NUMBER: 0001209191-20-048651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200826
FILED AS OF DATE: 20200828
DATE AS OF CHANGE: 20200828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Muller Lorenz
CENTRAL INDEX KEY: 0001771207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 201148590
MAIL ADDRESS:
STREET 1: C/O MILESTONE PHARMACEUTICALS, INC.
STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-26
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001771207
Muller Lorenz
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
0
1
0
0
Chief Commercial Officer
Common Stock
2020-08-26
4
M
0
5700
1.54
A
108386
D
Employee Stock Option (right to buy)
1.54
2020-08-26
4
M
0
5700
0.00
D
2027-10-11
Common Stock
5700
49754
D
The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
/s/ Eric Popp, Attorney-in-Fact
2020-08-28